Clinical Trial Update: Efficacy Study of MM-093 in Rheumatoid Arthritis Patients on Methotrexate (MTX) [Phase 2]

View source ↗

Summary

Phase 2 efficacy study of MM-093 in rheumatoid arthritis patients on methotrexate has completed; results are not provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• MM-093 (MM-093)

Snippet

Sponsor: Merrimack Pharmaceuticals | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED